Edition:
India

Panacea Biotec Ltd (PNCA.BO)

PNCA.BO on Bombay Stock Exchange

158.75INR
3:55pm IST
Change (% chg)

Rs25.90 (+19.50%)
Prev Close
Rs132.85
Open
Rs134.45
Day's High
Rs159.40
Day's Low
Rs134.00
Volume
149,516
Avg. Vol
30,418
52-wk High
Rs178.30
52-wk Low
Rs85.50

PNCA.BO

Chart for PNCA.BO

About

Panacea Biotec Limited is a health management company. The Company's principal business activity is the manufacture of allopathic pharmaceuticals preparations. The Company's segments include Vaccines, Formulations, Research and Development; Healthcare and Real estate activities. Its Vaccines, Formulations and Research &... (more)
No analyst recommendations are available for PNCA.BO.

Overall

Beta: 1.20
Market Cap(Mil.): Rs8,127.97
Shares Outstanding(Mil.): 61.25
Dividend: --
Yield (%): --

Financials

  PNCA.BO Industry Sector
P/E (TTM): -- 28.47 29.39
EPS (TTM): -- -- --
ROI: -- 13.57 13.06
ROE: -- 14.45 14.19

BRIEF-Panacea Biotec Dec qtr loss widens

* Dec quarter net loss 292.5 million rupees versus loss 173.8 million rupees year ago

14 Feb 2017

BUZZ-India's Panacea Biotec hits over 1-year high; U.S. FDA okays generic migraine drug

** Drug maker Panacea Biotec Ltd surges as much as 17.4 pct to its highest since Dec 8, 2015

18 Jan 2017

BRIEF-Panacea Biotec gets ANDA approval to market generic version of rizatriptan benzoate tablet

* Panacea Biotec Ltd says ANDA approval for us market and lta & award from un agencies for supply of pentavalent vaccine (easyfive-TT)

18 Jan 2017

BRIEF-Panacea Biotec announces receipt of EIR from USFDA

* Panacea Biotec Ltd. announces receipt of establishment inspection report (EIR) from USFDA Source text: http://corporates.bseindia.com/xml-data/corpfiling/AttachLive/462A15FE_20FB_40A7_883F_3D22A0646DA7_104704.pdf Further company coverage:

21 Nov 2016

BRIEF-Panacea Biotec Sept qtr loss narrows

* Panacea Biotec Ltd - sept quarter net loss 118.4 million rupees versus loss 170 million rupees year ago

11 Nov 2016

More From Around the Web

Earnings vs. Estimates